tiprankstipranks
Cabot Corp (CBT)
NYSE:CBT
Want to see CBT full AI Analyst Report?

Cabot (CBT) AI Stock Analysis

255 Followers

Top Page

CBT

Cabot

(NYSE:CBT)

Select Model
Select Model
Select Model
Neutral 69 (OpenAI - 5.2)
Rating:69Neutral
Price Target:
$96.00
▲(6.49% Upside)
Action:Downgraded
Date:08/17/26
CBT scores as moderately attractive, led by solid underlying profitability and a materially improved balance sheet, reinforced by earnings-call commentary showing confidence in FY26 guidance and strong Performance Chemicals/battery momentum. The score is held back by weaker recent earnings and free-cash-flow momentum, mixed near-term technical signals (negative MACD with neutral RSI), and a valuation that is acceptable but not clearly discounted (P/E ~24).
Positive Factors
Durable Profitability
Healthy operating and EBITDA margins indicate Cabot retains pricing, scale, and product-value advantages across specialty chemicals, providing a durable earnings base even when end-market demand and input costs fluctuate.
Negative Factors
Weak Revenue and Earnings Trajectory
Recent contraction in revenue and earnings indicates that durable profitability has not yet translated into consistent growth. Continued weakness could limit operating leverage, investment capacity, and the pace of shareholder returns.
Read all positive and negative factors
Positive Factors
Negative Factors
Durable Profitability
Healthy operating and EBITDA margins indicate Cabot retains pricing, scale, and product-value advantages across specialty chemicals, providing a durable earnings base even when end-market demand and input costs fluctuate.
Read all positive factors

Cabot Key Performance Indicators (KPIs)

Any
Any
Revenue by Geography
Revenue by Geography
Breaks down Cabot’s sales across regions so you can judge where demand is strongest and where the company is most exposed to local economic cycles, currency moves, or regulatory shifts. Useful for spotting regional growth opportunities and concentration risks that could affect future revenue and earnings stability.
Chart InsightsRegional revenue has rolled over from 2021–2022 peaks: Americas and EMEA show prolonged softening while APAC, still sizable, has pulled back from its highs. Management is offsetting that weakness with rapid, high‑margin Battery Materials growth and pricing/cost actions, but Reinforcement Materials weakness—driven by Asian competition—and planned capacity rationalizations (Argentina, Netherlands) create near‑term downside risk. The stock’s outcome now hinges on demand holding (to hit upper guidance) and flawless execution of pricing, savings and network cuts to sustain margins.
Data provided by:The Fly

Cabot (CBT) vs. SPDR S&P 500 ETF (SPY)

Cabot Business Overview & Revenue Model

Company Description
Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through two segments, Reinforcement Materials and Performance Chemicals. The company offers reinforcing carbons that are used in tires as a rubber r...
How the Company Makes Money
Cabot makes money primarily by manufacturing and selling performance materials—most notably carbon black—and capturing margin between its selling prices and its feedstock, energy, logistics, and operating costs. Its major revenue stream is the Rei...

Cabot Earnings Call Summary

Earnings Call Date:Aug 03, 2026
(Q3-2026)
|
% Change Since: |
Next Earnings Date:Nov 09, 2026
Earnings Call Sentiment Positive
The call presented a mix of meaningful positives — solid adjusted EPS growth, a strong Performance Chemicals quarter (+19% EBIT YoY), robust battery materials momentum (24% trailing EBITDA margin and $40M FY26 EBITDA target), healthy liquidity (~$1.3B) and continued shareholder returns — alongside material challenges, chiefly a significant ~24% YoY earnings decline in Reinforcement Materials driven by customer tire agreements, working capital pressure from raw material/oil volatility, and near-term margin normalization risks. Management reaffirmed guidance (narrowed range), highlighted disciplined capital allocation and ongoing investments in battery capacity, and expressed confidence in leadership continuity. Overall the positives modestly outweigh the negatives, with confidence in strategic growth areas balancing near-term headwinds.
Positive Updates
Adjusted EPS Growth
Adjusted earnings per share for Q3 fiscal 2026 were $1.67, an increase of 4% sequentially, reflecting solid execution across the portfolio.
Negative Updates
Reinforcement Materials Earnings Decline
Reinforcement Materials EBIT was $97 million in Q3 versus $128 million in the prior-year quarter, a decline of ~24% year-over-year, driven primarily by lower gross profit per ton from outcomes of calendar year 2026 tire customer agreements.
Read all updates
Q3-2026 Updates
Negative
Adjusted EPS Growth
Adjusted earnings per share for Q3 fiscal 2026 were $1.67, an increase of 4% sequentially, reflecting solid execution across the portfolio.
Read all positive updates
Company Guidance
Management tightened fiscal 2026 adjusted EPS guidance to $6.15–$6.45 (from $6.00–$6.50) while reaffirming Battery Materials EBITDA of ≈$40M for FY26 and reporting trailing-12-month Battery EBITDA margins of ≈24% at Q3-end; they narrowed FY26 CapEx to $200–$215M (Q3 CapEx $38M) and expect to invest ≈$125M in battery conductive‑additive capacity (U.S. brownfield + China) with new capacity targeted for 2028. Q3 operating cash flow was $75M after funding ≈$44M of higher net working capital; the company returned $24M in dividends in the quarter, has repurchased $101M YTD and expects to resume buybacks in Q4, ended Q3 with $250M cash and ≈$1.3B liquidity, has ≈$1.3B debt and a net debt/EBITDA of 1.4x, and plans to refinance a September bond in Q4. They updated the FY26 operating tax rate to 28%–30% (YTD 29%), and on a segment basis reported Reinforcement Materials Q3 EBIT $97M (EBITDA $117M, EBITDA margin 20%; volumes +5% YoY — Asia +10%, Americas +4%) with a modest sequential Q4 EBIT decline expected, and Performance Chemicals Q3 EBIT $68M (+19% YoY) with anticipated seasonal Q4 volume softness and gross‑profit‑per‑ton normalization as raw costs catch up.

Cabot Financial Statement Overview

Summary
Overall fundamentals are solid but not flawless. Profitability remains healthy (≈16% operating margin; ≈21% EBITDA margin), and the balance sheet is notably stronger after major debt reduction with attractive ROE (~18%). Offsetting this, earnings have softened versus prior periods and free cash flow has stepped down meaningfully versus last year, indicating weaker near-term profit and cash-conversion momentum.
Income Statement
72
Positive
Balance Sheet
84
Very Positive
Cash Flow
63
Positive
BreakdownTTMSep 2025Sep 2024Sep 2023Sep 2022Sep 2021
Income Statement
Total Revenue3.63B3.71B3.99B3.93B4.32B3.41B
Gross Profit832.00M940.00M960.00M839.00M885.00M799.00M
EBITDA690.00M794.00M761.00M685.00M537.00M615.00M
Net Income190.00M331.00M380.00M445.00M209.00M250.00M
Balance Sheet
Total Assets3.98B3.81B3.74B3.60B3.52B3.31B
Cash, Cash Equivalents and Short-Term Investments250.00M258.00M223.00M238.00M206.00M168.00M
Total Debt1.27B1.22B1.33B1.36B1.53B1.25B
Total Liabilities2.24B2.11B2.15B2.20B2.49B2.22B
Stockholders Equity1.60B1.55B1.43B1.26B898.00M947.00M
Cash Flow
Free Cash Flow281.00M391.00M451.00M351.00M-111.00M62.00M
Operating Cash Flow497.00M665.00M692.00M595.00M100.00M257.00M
Investing Cash Flow-275.00M-298.00M-235.00M-214.00M-118.00M-186.00M
Financing Cash Flow-234.00M-336.00M-415.00M-403.00M145.00M-60.00M

Cabot Technical Analysis

Technical Analysis Sentiment
Negative
Last Price90.15
Price Trends
50DMA
88.01
Negative
100DMA
83.30
Positive
200DMA
75.71
Positive
Market Momentum
MACD
-0.60
Positive
RSI
42.56
Neutral
STOCH
56.46
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CBT, the sentiment is Negative. The current price of 90.15 is above the 20-day moving average (MA) of 87.64, above the 50-day MA of 88.01, and above the 200-day MA of 75.71, indicating a neutral trend. The MACD of -0.60 indicates Positive momentum. The RSI at 42.56 is Neutral, neither overbought nor oversold. The STOCH value of 56.46 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CBT.

Cabot Risk Analysis

Cabot disclosed 21 risk factors in its most recent earnings report. Cabot reported the most risks in the "Tech & Innovation" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Cabot Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
$4.35B23.6012.07%2.02%-4.74%-53.83%
69
Neutral
$3.99B23.807.16%2.91%2.36%42.56%
69
Neutral
$5.54B35.7213.02%1.31%8.12%16.87%
62
Neutral
$7.69B53.421.59%-1.88%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
61
Neutral
$3.22B17.849.16%1.71%-0.57%81.10%
51
Neutral
$5.21B-13.84-30.38%24.25%-515.23%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CBT
Cabot
85.18
7.83
10.12%
FUL
H.B. Fuller Company
60.85
2.46
4.22%
AVNT
Avient
44.26
9.88
28.74%
SSL
Sasol
12.10
6.14
103.02%
SXT
Sensient Technologies
133.22
21.34
19.08%
PRM
Perimeter Solutions
30.45
12.03
65.31%

Cabot Corporate Events

Private Placements and FinancingRegulatory Filings and Compliance
Cabot Corporation Announces $350 Million Senior Notes Offering
Positive
Aug 14, 2026
On August 12, 2026, Cabot Corporation entered into an underwriting agreement with a syndicate led by Citigroup, J.P. Morgan, PNC Capital Markets and U.S. Bancorp Investments for the issuance and sale of $350 million of 4.950% notes due 2029. The n...
Business Operations and StrategyExecutive/Board Changes
Cabot announces CEO retirement and leadership succession
Neutral
Jul 30, 2026
Cabot Corporation announced on July 30, 2026 that President and CEO Sean Keohane will retire and step down from the board effective September 30, 2026, after nearly 25 years with the company and a decade as chief executive. He will remain as a non...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 17, 2026